← Eichor
Condition: Hiv I Infection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hiv I Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Antiretrovirals Combined With Antibodies for HIV-1 Cure In Africa
Phase 2 · 4 location(s) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Ot · NCT06205602Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial
NA · 1 location(s) · University of California, San Francisco · NCT07125235DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road)
Phase 2 · 4 location(s) · University Hospital, Caen · NCT06034938Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therap
Phase N/A · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT04160455Cannabis Use, Cognition, and the Endocannabinoid System in HIV
EARLY_Phase 1 · 1 location(s) · University of California, San Diego · NCT04883255Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Foll
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05470491Viral Infection of HSPC Impacts Hematopoiesis
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06458504Caspofungin for Pneumocystis Pneumonia in PLWHIV.
Phase N/A · 1 location(s) · Instituto Nacional de Enfermedades Respiratorias · NCT06691321A Phase Ⅱa Clinical Study of CL-197 Capsules
Phase 2 · 1 location(s) · Henan Genuine Biotech Co., Ltd. · NCT07308782Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals
Phase 3 · 4 location(s) · Chang Gung Memorial Hospital · NCT06507059A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test
NA · 3 location(s) · bioLytical Laboratories · NCT07563309Triage Survey for Infectious Disease Eligibility
Phase N/A · 1 location(s) · Brooklyn Clinical Research · NCT06492187Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy
Phase 1/Phase 2 · 2 location(s) · University of Melbourne · NCT05187429#AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-i
NA · 28 location(s) · Casper Rokx · NCT06900829Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
NA · 1 location(s) · Syracuse University · NCT06648629Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
Phase 2 · 2 location(s) · Massachusetts General Hospital · NCT06554717Impacts of HIV Treatment Regimens on Archived Drug Resistance
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT07643948Observational PIC Destination Cohort
Phase N/A · 4 location(s) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Ot · NCT05985642Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control
Phase 2 · 17 location(s) · ANRS, Emerging Infectious Diseases · NCT05300035A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and Wi
Phase 1 · 6 location(s) · BioNTech SE · NCT07392372HIV Resistance, Molecular Epidemiology and New Treatment Strategies in the Eastern European Region and in Russia
Phase N/A · 4 location(s) · Euresist Network GEIE · NCT06127290Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Emtricitabin
Phase 4 · 1 location(s) · José Antonio Mata Marín · NCT06907056Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Pa
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00039689Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults
Phase 1 · 1 location(s) · U.S. Army Medical Research and Development Command · NCT06205056Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch
Phase 3 · 3 location(s) · Chelsea and Westminster NHS Foundation Trust · NCT04892654PERSON-CENTERED APPROACHES TO VIREMIA: CONNECTION, RAPPORT, AND ENGAGEMENT STUDY
NA · 2 location(s) · Centre for Infectious Disease Research in Zambia · NCT07021092Analyses of Newly Diagnosed HIV Infection in Hong Kong
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT07725042Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir Among P
Phase 1/Phase 2 · 1 location(s) · University of Aarhus · NCT05668026Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT05389423Ending the Epidemic Interventions in the Dental Setting - UH3
NA · 3 location(s) · Columbia University · NCT06890988
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.